Literature DB >> 27490416

Proangiogenic Function of T Cells in Corneal Transplantation.

Antonio Di Zazzo1, Maryam Tahvildari, Brinda Subbarayal, Jia Yin, Thomas H Dohlman, Takenori Inomata, Alireza Mashaghi, Sunil K Chauhan, Reza Dana.   

Abstract

BACKGROUND: Corneal neovascularization increases the risk of T cell-mediated allograft rejection. Here, we investigate whether T cells promote angiogenesis in transplantation.
METHODS: Conventional effector T cells were collected from draining lymph nodes of allogeneic or syngeneic corneal transplanted BALB/c mice. T cells were either cocultured with vascular endothelial cells (VECs) to assess VEC proliferation or used in a mixed lymphocyte reaction assay. Messenger RNA (mRNA) expression of vascular endothelial growth factor (VEGF)-A, -C, and VEGF receptor 2 (VEGF-R2) in VECs was assessed by real-time PCR. VEGF-A protein expression was determined by enzyme-linked immunosorbent assay. Flow cytometry was used to analyze VEGF-R2 expression in corneal CD31 cells, and VEGF-A and IFNγ expression in corneal CD4 T cells.
RESULTS: Allogeneic T cells from high-risk (HR) grafted mice induced more VEC proliferation than those from syngeneic transplant recipients (P = 0.03). Vascular endothelial growth factor-A mRNA and protein expression were higher in T cells from draining lymph nodes (P = 0.03 and P = 0.04, respectively) and cornea (protein; P = 0.04) of HR compared with low-risk (LR) grafted hosts. Vascular endothelial growth factor-A, VEGF-C, and VEGF-R2 mRNA expression were increased in VECs when cocultured with T cells from HR transplants compared with LR transplants and naive mice. In addition, IFNγ blockade in T cell/VEC coculture increased VEC proliferation and VEGF-A protein expression, whereas blocking VEGF-A significantly reduced VEC proliferation (P = 0.04).
CONCLUSIONS: Allogeneic T cells from corneal transplant hosts promote VEC proliferation, probably via VEGF-A signaling, whereas IFNγ shows an antiangiogenic effect. Our data suggest that T cells are critical mediators of angiogenesis in transplantation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27490416      PMCID: PMC5290298          DOI: 10.1097/TP.0000000000001390

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  57 in total

1.  The role of extracellular matrix in corneal wound healing. Cornea 2013;32(suppl): s43-s45-retracted.

Authors:  Osamu Yamanaka; Takayoshi Sumioka; Shizuya Saika
Journal:  Cornea       Date:  2014-01       Impact factor: 2.651

Review 2.  Ocular neovascularization: an epidemiologic review.

Authors:  P Lee; C C Wang; A P Adamis
Journal:  Surv Ophthalmol       Date:  1998 Nov-Dec       Impact factor: 6.048

3.  Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.

Authors:  Y A Sidky; E C Borden
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

Review 4.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.

Authors:  Marco Presta; Patrizia Dell'Era; Stefania Mitola; Emanuela Moroni; Roberto Ronca; Marco Rusnati
Journal:  Cytokine Growth Factor Rev       Date:  2005-02-02       Impact factor: 7.638

5.  Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.

Authors:  Claus Cursiefen; Jingtai Cao; Lu Chen; Ying Liu; Kazuichi Maruyama; David Jackson; Friedrich E Kruse; Stanley J Wiegand; M Reza Dana; J Wayne Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

6.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.

Authors:  G E Peoples; S Blotnick; K Takahashi; M R Freeman; M Klagsbrun; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

7.  Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.

Authors:  Shintaro Nakao; Yasuaki Hata; Muneki Miura; Kousuke Noda; Yusuke N Kimura; Shuhei Kawahara; Takeshi Kita; Toshio Hisatomi; Toru Nakazawa; Yiping Jin; M Reza Dana; Michihiko Kuwano; Mayumi Ono; Tatsuro Ishibashi; Ali Hafezi-Moghadam
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

8.  Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.

Authors:  Eui-Sang Chung; Sunil Kumar Chauhan; Yiping Jin; Shintaro Nakao; Ali Hafezi-Moghadam; Nico van Rooijen; Qiang Zhang; Lu Chen; Reza Dana
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

9.  Inhibition of endothelial cell proliferation by gamma-interferon.

Authors:  R Friesel; A Komoriya; T Maciag
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

Review 10.  The role IL-1 in tumor-mediated angiogenesis.

Authors:  Elena Voronov; Yaron Carmi; Ron N Apte
Journal:  Front Physiol       Date:  2014-03-28       Impact factor: 4.566

View more
  10 in total

1.  Kinetics of Angiogenic Responses in Corneal Transplantation.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Sang-Mok Lee; Homer Chiang; Reza Dana
Journal:  Cornea       Date:  2017-04       Impact factor: 2.651

Review 2.  Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.

Authors:  Maryam Tahvildari; Afsaneh Amouzegar; William Foulsham; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2018-01-06       Impact factor: 9.261

Review 3.  When Clarity Is Crucial: Regulating Ocular Surface Immunity.

Authors:  William Foulsham; Giulia Coco; Afsaneh Amouzegar; Sunil K Chauhan; Reza Dana
Journal:  Trends Immunol       Date:  2017-12-14       Impact factor: 16.687

4.  Immunophysical analysis of corneal neovascularization: mechanistic insights and implications for pharmacotherapy.

Authors:  Youness Azimzade; Jiaxu Hong; Alireza Mashaghi
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

5.  The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection.

Authors:  William Foulsham; Sharad K Mittal; Takeshi Nakao; Giulia Coco; Yukako Taketani; Sunil K Chauhan; Reza Dana
Journal:  Sci Rep       Date:  2019-06-13       Impact factor: 4.379

6.  Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor.

Authors:  Sharad K Mittal; William Foulsham; Sachin Shukla; Elsayed Elbasiony; Masahiro Omoto; Sunil K Chauhan
Journal:  Stem Cells Transl Med       Date:  2019-06-10       Impact factor: 6.940

7.  Exploring the Key Genes and Pathways in the Formation of Corneal Scar Using Bioinformatics Analysis.

Authors:  Binfeng Liu; Ang Li; Hongbo Wang; Jialin Wang; Gongwei Zhai; Haohao Ma; Shiqing Feng; Liyun Liu; Yanzheng Gao
Journal:  Biomed Res Int       Date:  2020-01-18       Impact factor: 3.411

8.  Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival.

Authors:  Takenori Inomata; Keiichi Fujimoto; Yuichi Okumura; Jun Zhu; Kenta Fujio; Hurramhon Shokirova; Maria Miura; Mikiko Okano; Toshinari Funaki; Jaemyoung Sung; Naoko Negishi; Akira Murakami
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

9.  Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation.

Authors:  Hurramhon Shokirova; Takenori Inomata; Tsuyoshi Saitoh; Jun Zhu; Kenta Fujio; Yuichi Okumura; Ai Yanagawa; Keiichi Fujimoto; Jaemyoung Sung; Atsuko Eguchi; Maria Miura; Ken Nagino; Kunihiko Hirosawa; Mizu Kuwahara; Yasutsugu Akasaki; Hiroshi Nagase; Akira Murakami
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 10.  The Microenvironment That Regulates Vascular Wall Stem/Progenitor Cells in Vascular Injury and Repair.

Authors:  Ying Ma; Yuan Li; Yan Yang; Pengyun Li
Journal:  Biomed Res Int       Date:  2022-07-31       Impact factor: 3.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.